Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

Main Article Content

Alhossain A. Khalafallah *
Bernadene Fernandopulle
Terry Brain
(*) Corresponding Author:
Alhossain A. Khalafallah | alhossain@yahoo.com

Abstract

No Abstract Available


Downloads month by month

Downloads

Download data is not yet available.

Article Details

Author Biographies

Alhossain A. Khalafallah, Launceston General Hospital

Department of Haematology and MedicineThe Launceston General HospitalCharles StreetLaunceston, TAS 7250Australia

Bernadene Fernandopulle, Launceston General Hospital, Tasmania

Department of Haematology and MedicineThe Launceston General HospitalCharles StreetLaunceston, TAS 7250Australia

Terry Brain, Launceston General Hospital, Tasmania

Department of Pathology,The Launceston General HospitalCharles StreetLaunceston, TAS 7250Australia